AKT1 and familial mitral valve prolapse: In line with this, an increased number of plasma EMPs found in MVP patients leads to Akt/endothelial nitric oxide synthase (eNOS)-HSP90 signaling pathway inhibition and therefore to mitral valve endothelial dysfunction [14].